JEFFREY CHALFANT: Open Payments
NPI 1811935166 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,066 in 89 payments from 9 companies in 2025. Trend: 2023 $758 · 2024 $963 · 2025 $1,066
Food & beverage: $927Education: $139
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $278 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $239 |
| ABBVIE INC. | 20 | $187 |
| Lundbeck LLC | 17 | $164 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Alkermes, Inc. | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Tris Pharma Inc | 1 | $16 |
Products named: CAPLYTA, REXULTI, VRAYLAR, AUSTEDO XR, Auvelity, ARISTADA, COBENFY, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
